BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, January 17, 2026
Home » Topics » Science, BioWorld

Science, BioWorld
Science, BioWorld RSS Feed RSS

Placebo pill

Imperial psychedelic microdosing study pushes the envelope on participant blinding

March 5, 2021
By Cormac Sheridan
DUBLIN – A novel real-world study methodology that marries digital technology with a citizen science or do-it-yourself approach to “drug” procurement, formulation and administration has found – yet again – that the placebo remains one of the great wonders of the medical world.
Read More
Neuropathic pain
Bench Press

Macrophages dampen neuropathic pain

March 4, 2021
By Anette Breindl
BioWorld looks at translational medicine, including: Collagen means well in pancreatic cancer; Astrocytes are more inflammatory in bipolar disease.
Read More
Placebo effect graphic
Bench Press

Pain on the brain

March 2, 2021
By Anette Breindl
BioWorld looks at translational medicine, including: Neurons contribute to their own lack of regeneration.
Read More
Bispecific infographic

AGBT 2021: New bispecifics capture challenging targets

March 1, 2021
By Anette Breindl
A team led by researchers at Johns Hopkins University School of Medicine has developed bispecific antibodies that were able to target tumors driven by mutations in the tumor suppressor TP53 and the oncogene RAS, as well as subsets of T cells in T-cell malignancies.
Read More
Tape measure wrapped around feet on scale

Gene variants can increase fat, decrease cardiometabolic risk

Feb. 26, 2021
By Anette Breindl
In the public mind, fat and unhealthy are more or less synonymous. But reality is more complicated, as reality often is.
Read More
Cancer cell and DNA

Bacterial protease takes on ‘undruggable’ oncoprotein

Feb. 25, 2021
By Anette Breindl
Scientists, despite their best efforts, have not been able to identify a way to inhibit the oncoprotein Myc. Uropathogenic Escherichia coli, though, has apparently figured it out.
Read More
DNA NGS genome sequencing
Bench Press

Diverse populations, long reads give genome insights

Feb. 25, 2021
By Anette Breindl
BioWorld looks at translational medicine, including: Movement strengthens bones, and immunity; Atherosclerosis precedes clonal hematopoiesis.
Read More
Acute myeloid leukemia illustration
Bench Press

Antidiarrheal drug fights AML

Feb. 24, 2021
By Anette Breindl
BioWorld looks at translational medicine.
Read More
Brain clay model

Australian researchers identify potential treatment for fatal brain cancer in children

Feb. 23, 2021
By Tamra Sami
PERTH, Australia – The fight against diffuse intrinsic pontine glioma may finally see some progress, after experiments using 3D models of the tumor in animal studies showed that a combination therapy of the polyamine inhibitor AMXT-1501 (Aminex Therapeutics Inc.) and the ornithine decarboxylase 1 inhibitor difluoromethylornithine could eradicate cancer cells.
Read More
Capsules in blister packs
Bench Press

Tetracyclines curb neuropathic pain

Feb. 22, 2021
By Anette Breindl
BioWorld looks at translational medicine, including: Fighting Staphylococcus with Staphylococcus.
Read More
Previous 1 2 … 49 50 51 52 53 54 55 56 57 … 83 84 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 16, 2026.
  • SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

    BioWorld Science
    Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
  • Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

    BioWorld
    With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
  • Businesswoman pressing dollar sign on touchscreen

    JPM 2026: Year kicks off with biopharma Q4 revenue and guidance

    BioWorld
    It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing